[HTML][HTML] The International Epidemiology of Lung Cancer: geographical distribution and secular trends
This review presents the latest available international data for lung cancer incidence,
mortality and survival, emphasizing the established causal relationship between smoking …
mortality and survival, emphasizing the established causal relationship between smoking …
Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis
Z Tian, C Liang, Z Zhang, H Wen, H Feng, Q Ma… - World journal of surgical …, 2020 - Springer
Background Neuron-specific enolase (NSE) has become a widely used and easily
attainable laboratory assay of small cell lung cancer (SCLC). However, the prognostic value …
attainable laboratory assay of small cell lung cancer (SCLC). However, the prognostic value …
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors
Poorly differentiated neuroendocrine carcinomas (NECs) of the pancreas are rare malignant
neoplasms with a poor prognosis. The aim of this study was to determine the …
neoplasms with a poor prognosis. The aim of this study was to determine the …
Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo
BA Helfrich, J Kim, D Gao, DC Chan, Z Zhang… - Molecular cancer …, 2016 - AACR
Small-cell lung cancer (SCLC) cells have rapid proliferation, universal Rb inactivation, and
high rates of MYC family amplification, making aurora kinase inhibition a natural target …
high rates of MYC family amplification, making aurora kinase inhibition a natural target …
Relapsed small cell lung cancer: treatment options and latest developments
N Asai, Y Ohkuni, N Kaneko… - … advances in medical …, 2014 - journals.sagepub.com
According to recent analyses, there was a modest yet significant improvement in median
survival time and 5-year survival rate of limited stage small cell lung cancer (SCLC) in North …
survival time and 5-year survival rate of limited stage small cell lung cancer (SCLC) in North …
Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer
Z Huang, D Xu, F Zhang, Y Ying, L Song - Clinical and Translational …, 2016 - Springer
Purpose The aim of this study was (1) to evaluate and predict the value of ProGRP and NSE
in therapy and survival;(2) as well as to investigate the correlation between the ProGRP …
in therapy and survival;(2) as well as to investigate the correlation between the ProGRP …
The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with …
M Petrović, Z Bukumirić, V Zdravković, S Mitrović… - Medical oncology, 2014 - Springer
Lung cancer is the most common cancer, and small-cell lung cancer (SCLC) accounts for
around 20% of lung cancers. SCLC has a neuroendocrine cellular origin, and the tumor …
around 20% of lung cancers. SCLC has a neuroendocrine cellular origin, and the tumor …
Histologic assessment of tumor-associated CD45+ cell numbers is an independent predictor of prognosis in small cell lung cancer
W Wang, P Hodkinson, F McLaren, MJ Mackean… - Chest, 2013 - Elsevier
Background Small cell lung carcinoma (SCLC) continues to have a poor prognosis, with a 2-
year survival of< 20%. Studies have suggested that SCLC may affect the immune system to …
year survival of< 20%. Studies have suggested that SCLC may affect the immune system to …
[HTML][HTML] The role of radiation therapy in the management of small cell lung cancer
M Glatzer, S Schmid, M Radovic, M Früh, PM Putora - Breathe, 2017 - Eur Respiratory Soc
Small cell lung cancer (SCLC) is a very aggressive form of lung cancer. SCLC treatment
requires multidisciplinary management and timely treatment. Radiation therapy is an …
requires multidisciplinary management and timely treatment. Radiation therapy is an …
Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
T Hirose, K Okuda, T Yamaoka, K Ishida, S Kusumoto… - Lung cancer, 2011 - Elsevier
The purposes of this study were to assess the relationship of serum levels of pro-gastrin-
releasing protein (ProGRP) and neuron-specific enolase (NSE) at relapse with survival after …
releasing protein (ProGRP) and neuron-specific enolase (NSE) at relapse with survival after …